Novartis Investigative Site

Freemont, California 94538

0 studies enrolling now · 1 studies all time

What they study most

Rheumatoid Arthritis

Studies at this site

• Efficacy at 24 Weeks and Safety, Tolerability and Long Term Efficacy of Secukinumab (AIN457) in Patients With Active Rheumatoid Arthritis (RA) and an Inadequate Response to Anti-Tumor Necrosis Factor α (Anti-TNFα) Agents (CAIN457F2309 and CAIN457F2309E1) — Completed